VSTM FY 2014 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena

VSTMVerastem, Inc.

$375M

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$54M

Net Income

-$53M

EPS (Diluted)

$-24.82

Cash Flow

Operating Cash Flow

-$37M

Free Cash Flow

-$39M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$99M

Total Liabilities

$10M

Stockholders' Equity

$89M

Cash & Equivalents

$34M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$54M	-$41M	-29.5%
Net Income	-$53M	-$41M	-29.5%